1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
128. M WISSING, I DUPONT, P UNGER, Y CARPENTIER, D <strong>ABRAMOWICZ</strong><br />
A prospective, cross-over trial comparing cyclosporin a + atorvastatin to tacrolimus alone<br />
and tacrolimus + atorvastatin in hypercholesterolemic renal transplant patients<br />
American Transplant Congress, Boston, May 2004<br />
129. M WISSING, P UNGER, G BERKENBOOM, D <strong>ABRAMOWICZ</strong><br />
A prospective, cross-over trial comparing flow-mediated brachial artery vasodilation in<br />
hypercholesterolemic renal transplant patients treated with cyclosporine a + atorvastatin,<br />
tacrolimus alone and tacrolimus + atorvastatin<br />
American Transplant Congress, Boston, May 2004<br />
130. BEN BOUCHTA N., <strong>ABRAMOWICZ</strong> D., BROEDERS N., SURQUIN M., HOANG<br />
A.D., WISSING K.M.<br />
La conversion du tacrolimus à la cyclosporine A est associée à une du métabolisme<br />
glucidique de patients atteints d’un diabète novo après transplantation rénale.<br />
Société Francophone de Transplantation, Bruxelles, Décembre 2004<br />
131. BEN BOUCHTA N, D <strong>ABRAMOWICZ</strong>, N BROEDERS, M SURQUIN, A D HOANG,<br />
K M WISSING.<br />
Conversion from tacrolimus to cyclosporin a is associated with a significant improvement<br />
of glucose metabolism in patients with new-onset diabetes mellitus after renal<br />
transplantation.<br />
The third international congress on immunosuppression, San Diego, USA, December 2004<br />
132. BEN BOUCHTA N, GHISDAL L, <strong>ABRAMOWICZ</strong> D, BROEDERS N, SURQUIN M,<br />
HOANG AD, WISSING KM.<br />
Conversion from tacrolimus to cyclosporin a is associated with a significant improvement<br />
of glucose metabolism in patients with new-onset diabetes mellitus after renal<br />
transplantation.<br />
American Transplant Congress, Seattle, May 2005.<br />
133. GLOTZ D, CHARPENTIER B, <strong>ABRAMOWICZ</strong> D, LANG P, ROSTAING L, RIFLE G,<br />
VANRENTERGHEM Y, BERTHOUX F, BOURBIGOT B, DELAHOUSSE M,<br />
CHALOPIN JM.<br />
Six months preliminary results of a randomized trial comparing sirolimus (SRL) versus<br />
tacrolimus (FK) in 141 transplant patients receiving a cadaveric renal graft.<br />
American Transplant Congress, Seattle, May 2005.<br />
134. BROEDERS N, MASCART F, WISSING M, <strong>ABRAMOWICZ</strong> D<br />
Evolution of anti-tetanus toxoid and anti-pneumococal antibodies during the first year<br />
57
Change language